Message to attendees of Public Meeting on Patient-Focused Drug Development for Long COVID

U.S. Food and Drug Administration sent this bulletin at 03/19/2024 01:10 PM EDT

If your email program has trouble displaying this email, view as a webpage.

We are pleased to announce the publication of the Voice of the Patient Report for Long COVID that summarizes the April 25^th, 2023 FDA public meeting on Patient-Focused Drug Development for Long COVID.

The report has been posted online and can be found here: https://www.fda.gov/drugs/news-events-human-drugs/public-meeting-patient-focused-drug-development-long-covid-04252023

We are thankful for your participation and grateful to the individuals with Long COVID, their loved ones, and others who shared their perspectives during the meeting and as part of the public docket.

Kind regards,

FDA PFDD Staff

Manage Subscriptions | Unsubscribe All | Help